Sarepta Director Sells $123,207 in Stock to Cover RSU Taxes as Shares Trade Near $16.40
Sarepta Therapeutics director Stephen Mayo sold 7,239 shares of common stock on March 12, 2026, at $17.02 per share for $123,207 to satisfy tax obligations arising from vested restricted stock units. The transaction leaves Mayo with 1,765 shares directly held. Sarepta shares were trading near $16.40, a decline of 84% from their 52-week high of $103…